9,953
Total Claims
$1.0M
Drug Cost
772
Beneficiaries
$1,333
Cost/Patient
Peer Comparison vs. 109,535 Physician Assistant providers
+85%
Cost per patient vs peers
$1,333 vs $719 avg
+96%
Brand preference vs peers
13.1% vs 6.7% avg
Brand vs Generic
87% generic
Brand: 1,278 claims · $831K
Generic: 8,509 claims · $187K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 124 | $176K |
| Empagliflozin | 69 | $81K |
| Insulin Glargine,hum.Rec.Anlog | 67 | $61K |
| Insulin Glargine,hum.Rec.Anlog | 66 | $51K |
| Apixaban | 41 | $39K |
| Insulin Detemir | 23 | $29K |
| Rivaroxaban | 16 | $23K |
| Insulin Lispro | 27 | $23K |
| Fluticasone Propionate | 47 | $18K |
| Tiotropium Bromide | 23 | $17K |
| Fluticasone/Vilanterol | 32 | $17K |
| Insulin Detemir | 15 | $14K |
| Linaclotide | 13 | $14K |
| Insulin Aspart | 13 | $13K |
| Insulin Lispro | 17 | $13K |
Prescribing Profile
Patient Profile
70
Avg Age
48%
Female
1.28
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data